Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

70572 Human Male Genomic DNA

High molecular weight, high purity DNA for any application

Human Male Genomic DNA MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
70572
Purchase on Sigma-Aldrich

Přehled

Replacement Information

Products

Katalogové čísloBalení ks/bal.
70572-3 Skleněná láhev 100 μg
Description
OverviewGenomic DNAs are highly purified preparations of high molecular weight genomic DNA from a variety of organisms. The isolation protocol minimizes shearing and removes contaminants that inhibit enzymatic procedures. Novagen genomic DNA is qualified for genomic analysis (including PCR) and library construction. At least 90% of the DNA is greater than 100 kbp in size, as analyzed by CHEF gel electrophoresis (> 50 kbp for S. cerevisiae). No inhibition of restriction enzyme activity is observed, and the DNA is free of contaminating RNA and protein.

The DNA is supplied in 10 mM Tris-HCl, pH 8.0, 1 mM EDTA (TE). Pipet with a wide-bore pipet tip to minimize shearing.

Catalogue Number70572
Brand Family Novagen®
References
Product Information
Quality LevelMQ200
Applications
Biological Information
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Blue Ice Only
Toxicity Standard Handling
Storage +2°C to +8°C
Avoid freeze/thaw Avoid freeze/thaw
Do not freeze Ok to freeze
Packaging Information
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Katalogové číslo GTIN
70572-3 04055977273779

Documentation

Human Male Genomic DNA Certificates of Analysis

TitleLot Number
70572

Citations

Název
  • Patrick J. Bastian, et al. (2007) Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy. Clinical Cancer Research 13, 5361-5367.
  • Jane L. Boddy, et al. (2005) Prospective study of quantitation of plasma DNA levels in the diagnosis of malignant versus benign prostate disease. Clinical Cancer Research 11, (1394- 1399).
  • Jun Zhang, et al. (2005) DNA Methylation in Anal Intraepithelial Lesions and Anal Squamous Cell Carcinoma. Clinical Cancer Research 11, 6544-6549.
    		•